Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2457 Target Snapshot

Polyunsaturated fatty acid lipoxygenase ALOX15B · SINGLE PROTEIN · Homo sapiens

6,993Compounds
25Assays
1Approved Drugs
130.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt O15296. Use UniProt O15296 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt O15296 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Polyunsaturated fatty acid lipoxygenase ALOX15B as ChEMBL target CHEMBL2457, mapped to UniProt O15296. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Polyunsaturated fatty acid lipoxygenase ALOX15B
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL2457
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
O15296
Polyunsaturated fatty acid lipoxygenase ALOX15B
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Polyunsaturated fatty acid lipoxygenase ALOX15B is the right protein anchor across sources, using UniProt O15296 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelPolyunsaturated fatty acid lipoxygenase ALOX15B
UniProt AccessionO15296
Component TypeProtein
Sequence Length676 aa

Polyunsaturated fatty acid lipoxygenase ALOX15B

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Polyunsaturated fatty acid lipoxygenase ALOX15B, mapped to UniProt O15296. Sequence length is 676 aa.

Mapped IDO15296
Review namePolyunsaturated fatty acid lipoxygenase ALOX15B
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Approved
Assay Mix

Activity Type Distribution

IC50126.0
EC504.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL235920 7.29 IC50 51.0 Preclinical
CHEMBL399821 6.83 IC50 147.0 Preclinical
CHEMBL1390514 6.47 IC50 340.0 Preclinical
CHEMBL392977 6.4 IC50 402.0 Preclinical
CHEMBL391659 6.36 IC50 433.0 Preclinical
CHEMBL1520238 6.28 IC50 530.0 Preclinical
CHEMBL1452107 6.22 EC50 600.0 Preclinical
CHEMBL1390514 6.12 EC50 750.0 Preclinical
CHEMBL1352020 6.06 IC50 870.0 Preclinical
CHEMBL1352020 5.89 EC50 1300.0 Preclinical
Distribution

pChEMBL Value Distribution

1
5.0
4
5.5
7
6.0
1
6.5
1
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

26
Total Assays
21
Tested Compounds
3
Assay Types
Binding — 21 assays, 21 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 14 10 5.3
cell-based format 4 9 6.1
assay format 2 2 4.9
tissue-based format 1 0
Functional — 3 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 3 0
ADME — 2 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 2 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine